Asserter profile

Astellas Pharma Inc.

operating company4 patents now5 ever1 case filed during tenure4 connections

Also seen as: ASTELLAS PHARMA INC.

Two-hop network

Edges marked ⚖️ overlap with at least one infringement suit filed during the receiving entity’s tenure with the patent. Bold-bordered = this entity. Red = NPE; orange = shell LLC; green = defensive aggregator; blue = operating company.

flowchart LR
    Nastellas_pharma["Astellas Pharma Inc."]
    Ntoyota_hiroyasu_irie_ryousuke_oba_shinsuke_kanbayashi_atsush["TOYOTA, Hiroyasu; IRIE, Ryousuke; OBA,…"]
    Nmichiel_de_vries_walter_krauwinkel["Michiel de Vries; Walter Krauwinkel"]
    Ntaoufik_ouatas["Taoufik Ouatas"]
    Nfujisawa_pharmaceutical["Fujisawa Pharmaceutical Co., Ltd."]
    Ngoto_toshio_hatanaka_hiroshi_kino_tohru_okuhara_masakuni_tan["GOTO, TOSHIO; HATANAKA, HIROSHI; KINO,…"]
    Nhata_takehisa_kagayama_akira_kimura_sumihisa_murata_saburo_t["Hata, Takehisa; Kagayama, Akira; Kimura…"]
    Nyamanaka_masayuki_shimojo_fumio_ueda_satoshi_and_others["Yamanaka, Masayuki; Shimojo, Fumio; Ued…"]
    Ntoyota_hiroyasu_irie_ryousuke_oba_shinsuke_kanbayashi_atsush -->|"2023 · Assignment of Assignors Interest · 11839689"| Nastellas_pharma
    Nmichiel_de_vries_walter_krauwinkel -->|"2017 · Confirmatory Assignment · 12161628"| Nastellas_pharma
    Ntaoufik_ouatas -->|"2019 · Confirmatory Assignment · 12161628"| Nastellas_pharma
    Nfujisawa_pharmaceutical -->|"2005 · Merger · 4894366"| Nastellas_pharma
    Nfujisawa_pharmaceutical -->|"2005 · Merger / Change of Name · 5601844"| Nastellas_pharma
    Nfujisawa_pharmaceutical -->|"2005 · Merger / Change of Name · 6387918"| Nastellas_pharma
    Ngoto_toshio_hatanaka_hiroshi_kino_tohru_okuhara_masakuni_tan -->|"1989 · Assignment · 4894366"| Nfujisawa_pharmaceutical
    Nhata_takehisa_kagayama_akira_kimura_sumihisa_murata_saburo_t -->|"1995 · Assignment · 5601844"| Nfujisawa_pharmaceutical
    Nyamanaka_masayuki_shimojo_fumio_ueda_satoshi_and_others -->|"1999 · Assignment · 6387918"| Nfujisawa_pharmaceutical
    classDef focal fill:#fef3c7,stroke:#92400e,stroke-width:3px,color:#1c1917
    classDef npe fill:#fee2e2,stroke:#be123c,stroke-width:2px,color:#1c1917
    classDef shell fill:#fed7aa,stroke:#9a3412,stroke-width:2px,color:#1c1917
    classDef defensive fill:#dcfce7,stroke:#15803d,stroke-width:2px,color:#1c1917
    classDef operating fill:#e0f2fe,stroke:#075985,stroke-width:1px,color:#1c1917
    class Nastellas_pharma focal
    class Nfujisawa_pharmaceutical operating

Patents currently held (4)

Patents previously held (1)

Connected entities (4)

Correspondent attorneys (1)

Attorneys / firms recorded with USPTO when this entity received a patent. Recurrence is the signal — many firms do both NPE and operating-company patent work, so a single appearance doesn’t mean much.